MACQUARIE GROUP LTD - CONSTELLATION PHARMCETICLS I ownership

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$23,000
-97.9%
686
-98.5%
0.00%
-100.0%
Q1 2021$1,084,000
+4069.2%
46,367
+5074.9%
0.00%
Q4 2020$26,000
+44.4%
8960.0%0.00%
Q3 2020$18,000
-33.3%
8960.0%0.00%
Q2 2020$27,0008960.00%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q3 2021
NameSharesValueWeighting ↓
TRV GP, LLC 3,034,083$37,259,00042.17%
Svennilson Peter 4,677,939$57,446,00016.42%
VHCP Management II, LLC 726,677$8,924,0002.81%
Casdin Capital, LLC 1,523,960$18,714,229,0001.75%
P.A.W. CAPITAL CORP 120,000$1,474,0001.59%
Cormorant Asset Management, LP 1,271,685$15,616,0000.90%
VHCP Management III, LLC 66,667$819,0000.38%
Orbimed Advisors 835,842$10,264,0000.16%
Hillhouse Capital Management 317,921$3,904,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 183,600$2,255,0000.08%
View complete list of CONSTELLATION PHARMCETICLS I shareholders